Bergen, Norway 4 June 2022
Lifecare achieved the two major milestones for 1H2022 in June, the clinicalstudy announced 23 June has started and Lifecare continue to strengthen theorganization. Read more in the Lifecare July newsletter:https://lifecare.no/news/information-from-lifecare-july-2022/
This is Lifecare Lifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for correct and continuous monitoring of bloodsugar in people with diabetes. The Company's patented technology also has thepotential for use in various biomarkers. Lifecare AS is listed on EuronextGrowth (LIFE).
Further information Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.attme.dev,+47 40 05 90 40
This stock exchange announcement was published by Joacim Holter, CEO at LifecareAS, on 04.07.22 at 08:59 CET.